Transmit.Live Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
119
- Latest Deal Type
-
Accelerator/Inc
- Financing Rounds
-
6
Transmit.Live General Information
Description
Operator of a media broadcasting platform designed to simplify the process of live-streaming distribution and promotion. The company's platform is based on enterprise software that is designed to monetize and distribute live or simulated live channels to multiple platforms with in-content ad experiences dynamically injected across all devices, enabling media operators to create new inventory supplies that sustain and enhance the viewer experience.
Contact Information
Website
www.transmit.liveCorporate Office
- 118 East 28th Street 808
- New York, NY 10016
- United States
Corporate Office
- 118 East 28th Street 808
- New York, NY 10016
- United States
Transmit.Live Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Transmit.Live Comparisons
Industry
Financing
Details
Transmit.Live Competitors (3)
One of Transmit.Live’s 3 competitors is Wurl, a Formerly VC-backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wurl | Formerly VC-backed | Palo Alto, CA | ||||
| Amagi | Private Equity-Backed | Bengaluru, India | ||||
| TripleLift | Private Equity-Backed | New York, NY |
Transmit.Live Patents
Transmit.Live Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20060233773-A1 | Prenatally administering and/or postnatally administering to the subject a therapeutically effective amount of lactobacillus gg prior to allergic sensitization of the subject | Active | 15-Apr-2005 | ||
| US-7303745-B2 | Prenatally administering and/or postnatally administering to the subject a therapeutically effective amount of lactobacillus gg prior to allergic sensitization of the subject | Inactive | 15-Apr-2005 | ||
| US-20080085267-A1 | Using lactobacillus gg (lgg) as therapeutic tool in treatment and prevention of respiratory allergies | Active | 15-Apr-2005 | ||
| US-7923006-B2 | Using lactobacillus gg (lgg) as therapeutic tool in treatment and prevention of respiratory allergies | Active | 15-Apr-2005 | ||
| US-20080118483-A1 | Using prenatal and/or postnatal administration of lactobacillus as therapeutic in treatment of respiratory system disorders | Active | 15-Apr-2005 | A61K35/745 |
Transmit.Live Signals
Transmit.Live Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Transmit.Live FAQs
-
When was Transmit.Live founded?
Transmit.Live was founded in 2016.
-
Where is Transmit.Live headquartered?
Transmit.Live is headquartered in New York, NY.
-
What is the size of Transmit.Live?
Transmit.Live has 119 total employees.
-
What industry is Transmit.Live in?
Transmit.Live’s primary industry is Media and Information Services (B2B).
-
Is Transmit.Live a private or public company?
Transmit.Live is a Private company.
-
What is Transmit.Live’s current revenue?
The current revenue for Transmit.Live is .
-
How much funding has Transmit.Live raised over time?
Transmit.Live has raised $9.8M.
-
Who are Transmit.Live’s investors?
Comcast NBCUniversal SportsTech, LionTree, Comcast Ventures, and SC.Holdings have invested in Transmit.Live.
-
Who are Transmit.Live’s competitors?
Wurl, Amagi, and TripleLift are competitors of Transmit.Live.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process